ஆயுட்காலம் இருதய நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆயுட்காலம் இருதய நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆயுட்காலம் இருதய நிறுவனம் Today - Breaking & Trending Today

Magnets in iPhone series 12 can interfere with some implanted cardiac devices


American Heart Association
Research Highlights:
For some cardiac patients, a pacemaker or implantable cardioverter defibrillator is needed to help keep the heart beating normally.
People who have an implanted cardiac device should not be near electronic devices that have magnets or produce electromagnetic waves because they can interfere with the cardiac device’s functions.
Magnets in the iPhone 12® series, which allow the phones to be charged wirelessly, are stronger than the magnets found in earlier generations of iPhones.
In a small study of different types of pacemakers and implantable cardioverter defibrillators, 11 of 14 cardiac devices experienced interference when an iPhone 12 Max Pro was held close to the cardiac device (within 1.5 cm), even when the device was still in the manufacturer’s sealed package. ....

United States , Rhode Island , Miriam Hospital , Arismendy Nunez Garcia , Michael Wu , Cao Thach Tran , American Heart Association , Clinical Cardiac Electrophysiology Fellowship Program , Brown University Warren Alpert School Of Medicine , Journal Of The American Heart Association , Drug Administration , Miriam Hospital Lifespan Cardiovascular Institute , Research Highlights , Lifespan Cardiovascular Institute , Brown University , Warren Alpert School , Vascular Institute , Pittsburgh School , Fahd Nadeem , United States , Rhode Island , University Of Pittsburgh , Brown University , Medical Devices , Heart Disease , Heart Rhythm ,

FFR Disappoints as Guide for PCI on Non-Culprit Lesions in STEMI


email article
Hemodynamic assessment did not improve guidance for complete revascularization in multivessel stenting for patients with ST-segment elevation MI (STEMI), according to the FLOWER-MI trial.
Fractional flow reserve (FFR) was no better than angiography at guiding percutaneous coronary intervention (PCI) on nonculprit lesions in terms of 1-year clinical outcomes among more than 1,000 study participants, reported Etienne Puymirat, of the European Hospital of Georges Pompidou in Paris.
By then, the combined rate of all-cause mortality, MI, or unplanned hospitalization leading to urgent revascularization was similar between patients randomized to FFR or angiographic guidance (5.5% vs 4.2%, HR 1.32, 95% CI 0.78-2.23). There were no differences in individual endpoint components either, Puymirat said at the American College of Cardiology (ACC) virtual meeting. FLOWER-MI results were simultaneously published in the ....

Stanford University , United States , New York , Rhode Island , France General , Nicole Lou , William Fearon , Etienne Puymirat , Roxana Mehran , Herbert Aronow , Georges Pompidou , Lifespan Cardiovascular Institute , American College Of Cardiology , European Hospital , American College , New England Journal , Mount Sinai Hospital , New York City , Alpert Medical School , Brown University , Medpage Today , England Journal , Englj Med , ஸ்டான்போர்ட் பல்கலைக்கழகம் , ஒன்றுபட்டது மாநிலங்களில் , புதியது யார்க் ,